-
A Study To Evaluate XEN1101 As Adjunctive Therapy In Primary Generalized Tonic-Clonic Seizures
Jacksonville, FL
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized tonic-clonic seizures (PGTCS).
-
A Study of Imaging and Systemic Markers in Patients with Epilepsy
Rochester, MN
The purpose of this study is to investigate if blood and/or MRI markers of inflammation and immune system activation may show changes in relation to when you have a seizure, and to noninvasively detect seizure related structural and functional alterations in acute seizure by MRI.
-
Investigate The Efficacy And Safety Of Carisbamate (YKP509) As Adjunctive Treatment For Seizures Associated With Lennox-Gastaut Syndrome In Children And Adults
Rochester, MN
The purpose of this study is to evaluate the effectiveness of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in pediatric and adult subjects diagnosed with Lennox Gastaut Syndrome (LGS).